This inventor holds 1 USPTO granted patent. Top assignee: Synapse B.v.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: **The Innovative Contributions of Bas H De Laat in Hematology**
Introduction
Bas H De Laat, located in Maastricht, Netherlands, is a notable inventor recognized for his significant contributions to the field of hematology. His inventive prowess is demonstrated through his patent, which reflects a combination of innovative thinking and practical application in medical diagnostics.
Latest Patents
Bas H De Laat holds one patent titled "Simultaneous measurement of thrombin generation and clot strength in plasma and whole blood." This patent introduces a groundbreaking method for the simultaneous measurement of proteolytic enzyme generation and clot strength in plasma or whole blood, as well as any suitable biological sample derived from blood. The method employs a detectable substrate that releases a moiety upon reaction with the targeted proteolytic enzyme, along with elements that measure the viscosity increase in clot strength. This invention holds the potential to enhance diagnostic accuracy in clinical settings.
Career Highlights
Bas is currently associated with Synapse B.V., a company dedicated to advancing innovations in healthcare and medical technology. His work at Synapse B.V. emphasizes the integration of scientific research and practical applications in diagnostic measures, particularly in understanding blood coagulation processes.
Collaborations
Throughout his career, Bas H De Laat has worked alongside accomplished colleagues such as Hendrik Coenraad Hemker and Leonie Pelkmans. Their collaborative efforts demonstrate a collective commitment to pushing the boundaries of research and development in hematology.
Conclusion
Bas H De Laat exemplifies the spirit of innovation in the medical field through his patent on thrombin generation measurement and clot strength analysis. His contributions are poised to impact both clinical practices and research, making significant strides towards improved patient care and diagnostic methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile